Summary

Plasmid Purification Market Summary

The global plasmid purification market size was estimated at USD 1.91 billion in 2024 and is projected to reach USD 5.28 billion by 2033, growing at a CAGR of 12.09% from 2025 to 2033. The growing demand for recombinant DNA technology products and technological advancements in plasmid purification are some of the factors driving market growth.

Moreover, the rising acceptance of cell and gene therapy to treat chronic diseases further propels market growth.

Global Plasmid Purification Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global plasmid purification market report based on product & service, grade, application, end-use, and region.

• Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
• Products
o Instruments
o Kits & Reagents
• Services
• Grade Outlook (Revenue, USD Million, 2021 - 2033)
• Molecular Grade
• Transfection Grade
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Cloning & Protein Expression
• Transfection & Gene Editing
• Others
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Thailand
• Latin America
o Brazil
o Argentina
• MEA
o South Africa
o Saudi Arabia
o UAE
o Kuwait

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product & Service Segment
1.2.2. Grade Segment
1.2.3. Application Segment
1.2.4. End Use Segment
1.3. Information Analysis
1.3.1. Market formulation & data visualization
1.4. Data Validation & Publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Plasmid Purification Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing demand for recombinant DNA technology (rDNA) products
3.2.1.2. Technological advancements in plasmid purification
3.2.1.3. Increasing adoption of cell and gene therapies
3.2.2. Market restraint analysis
3.2.2.1. Ethical constraints related to the use of rDNA technology
3.3. Plasmid Purification Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Plasmid Purification Market: Product & Service Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Plasmid Purification Market Product & Service Movement Analysis
4.3. Global Plasmid Purification Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
4.4. Products
4.4.1. Products market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2. Instruments
4.4.2.1. Instruments market estimates and forecasts 2021 to 2033 (USD Million)
4.4.3. Kits & Reagents
4.4.3.1. Kits & reagents market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Services
4.5.1. Services market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Plasmid Purification Market: Grade Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Plasmid Purification Market Grade Movement Analysis
5.3. Global Plasmid Purification Market Size & Trend Analysis, by Grade, 2021 to 2033 (USD Million)
5.4. Molecular Grade
5.4.1. Molecular-grade market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Transfection Grade
5.5.1. Transfection grade market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Plasmid Purification Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Plasmid Purification Market Application Movement Analysis
6.3. Global Plasmid Purification Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Cloning & Protein Expression
6.4.1. Cloning & protein expression market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Transfection & Gene Editing
6.5.1. Transfection & gene editing market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Others
6.6.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Plasmid Purification Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Plasmid Purification Market End Use Movement Analysis
7.3. Global Plasmid Purification Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.4. Pharmaceutical & Biotechnology Companies
7.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)
7.5. Academic & Research Institutes
7.5.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Contract Research Organizations
7.6.1. Contract research organizations market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Plasmid Purification Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2033
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
8.4. North America
8.4.1. U.S.
8.4.1.1. Key country dynamics
8.4.1.2. Competitive scenario
8.4.1.3. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
8.4.2. Canada
8.4.2.1. Key country dynamics
8.4.2.2. Competitive scenario
8.4.2.3. Canada market estimates and forecasts 2021 to 2033 (USD Million)
8.4.3. Mexico
8.4.3.1. Key country dynamics
8.4.3.2. Competitive scenario
8.4.3.3. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
8.5. Europe
8.5.1. UK
8.5.1.1. Key country dynamics
8.5.1.2. Competitive scenario
8.5.1.3. UK market estimates and forecasts 2021 to 2033 (USD Million)
8.5.2. Germany
8.5.2.1. Key country dynamics
8.5.2.2. Competitive scenario
8.5.2.3. Germany market estimates and forecasts 2021 to 2033 (USD Million)
8.5.3. France
8.5.3.1. Key country dynamics
8.5.3.2. Competitive scenario
8.5.3.3. France market estimates and forecasts 2021 to 2033 (USD Million)
8.5.4. Italy
8.5.4.1. Key country dynamics
8.5.4.2. Competitive scenario
8.5.4.3. Italy market estimates and forecasts 2021 to 2033 (USD Million)
8.5.5. Spain
8.5.5.1. Key country dynamics
8.5.5.2. Competitive scenario
8.5.5.3. Spain market estimates and forecasts 2021 to 2033 (USD Million)
8.5.6. Norway
8.5.6.1. Key country dynamics
8.5.6.2. Competitive scenario
8.5.6.3. Norway market estimates and forecasts 2021 to 2033 (USD Million)
8.5.7. Sweden
8.5.7.1. Key country dynamics
8.5.7.2. Competitive scenario
8.5.7.3. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
8.5.8. Denmark
8.5.8.1. Key country dynamics
8.5.8.2. Competitive scenario
8.5.8.3. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
8.6. Asia Pacific
8.6.1. Japan
8.6.1.1. Key country dynamics
8.6.1.2. Competitive scenario
8.6.1.3. Japan market estimates and forecasts 2021 to 2033 (USD Million)
8.6.2. China
8.6.2.1. Key country dynamics
8.6.2.2. Competitive scenario
8.6.2.3. China market estimates and forecasts 2021 to 2033 (USD Million)
8.6.3. India
8.6.3.1. Key country dynamics
8.6.3.2. Competitive scenario
8.6.3.3. India market estimates and forecasts 2021 to 2033 (USD Million)
8.6.4. Australia
8.6.4.1. Key country dynamics
8.6.4.2. Competitive scenario
8.6.4.3. Australia market estimates and forecasts 2021 to 2033 (USD Million)
8.6.5. South Korea
8.6.5.1. Key country dynamics
8.6.5.2. Competitive scenario
8.6.5.3. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
8.6.6. Thailand
8.6.6.1. Key country dynamics
8.6.6.2. Competitive scenario
8.6.6.3. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
8.7. Latin America
8.7.1. Brazil
8.7.1.1. Key country dynamics
8.7.1.2. Competitive scenario
8.7.1.3. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
8.7.2. Argentina
8.7.2.1. Key country dynamics
8.7.2.2. Competitive scenario
8.7.2.3. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
8.8. MEA
8.8.1. South Africa
8.8.1.1. Key country dynamics
8.8.1.2. Competitive scenario
8.8.1.3. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
8.8.2. Saudi Arabia
8.8.2.1. Key country dynamics
8.8.2.2. Competitive scenario
8.8.2.3. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
8.8.3. UAE
8.8.3.1. Key country dynamics
8.8.3.2. Competitive scenario
8.8.3.3. UAE market estimates and forecasts 2021 to 2033 (USD Million)
8.8.4. Kuwait
8.8.4.1. Key country dynamics
8.8.4.2. Competitive scenario
8.8.4.3. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
9.4.1. Merck KGaA
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product/Service benchmarking
9.4.1.4. Strategic initiatives
9.4.2. QIAGEN
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product/Service benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Thermo Fisher Scientific, Inc.
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product/Service benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Takara Bio
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product/Service benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Promega Corporation
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product/Service benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Zymo Research
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product/Service benchmarking
9.4.6.4. Strategic initiatives
9.4.7. MP BIOMEDICALS
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product/Service benchmarking
9.4.7.4. Strategic initiatives
9.4.8. New England Biolabs
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product/Service benchmarking
9.4.8.4. Strategic initiatives
9.4.9. MCLAB
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product/Service benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Applied Biological Materials, Inc.
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product/Service benchmarking
9.4.10.4. Strategic initiatives